Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau, Vincent M. Isabella, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 297

Showing 26-50 of 297 citing articles:

Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 42
Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms
Rocco Mazzolini, Irene Rodríguez-Arce, Laia Fernández‐Barat, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 8, pp. 1089-1098
Open Access | Times Cited: 39
Advanced delivery systems for peptide antibiotics
Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114733-114733
Open Access | Times Cited: 36
Next generation probiotics: Engineering live biotherapeutics
Sanjeeva Kumar Murali, Thomas J. Mansell
Biotechnology Advances (2024) Vol. 72, pp. 108336-108336
Closed Access | Times Cited: 17
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
AIEgens for microbial detection and antimicrobial therapy
Haotian Bai, Wei He, Joe H. C. Chau, et al.
Biomaterials (2020) Vol. 268, pp. 120598-120598
Open Access | Times Cited: 107
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Brendan Fu‐Long Sieow, K.S. Wun, Wei Peng Yong, et al.
Trends in cancer (2020) Vol. 7, Iss. 5, pp. 447-464
Open Access | Times Cited: 104
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis
Xu Yan, Xin-Yi Liu, Dian Zhang, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2344-2357
Open Access | Times Cited: 91
Stimuli-responsive engineered living materials
Laura K. Rivera‐Tarazona, Zachary T. Campbell, Taylor H. Ware
Soft Matter (2020) Vol. 17, Iss. 4, pp. 785-809
Closed Access | Times Cited: 88
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Vasile Coman, Dan Cristian Vodnar
Experimental Gerontology (2020) Vol. 141, pp. 111095-111095
Open Access | Times Cited: 87
Structural diversity, functional aspects and future therapeutic applications of human gut microbiome
Soma Ghosh, Sreemanta Pramanik
Archives of Microbiology (2021) Vol. 203, Iss. 9, pp. 5281-5308
Open Access | Times Cited: 84
Protection of Anaerobic Microbes from Processing Stressors Using Metal–Phenolic Networks
Gang Fan, Pris Wasuwanich, Mariela R. Rodriguez-Otero, et al.
Journal of the American Chemical Society (2021) Vol. 144, Iss. 6, pp. 2438-2443
Open Access | Times Cited: 81
Theranostic cells: emerging clinical applications of synthetic biology
Monica P. McNerney, Kailyn E. Doiron, Tai L. Ng, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 730-746
Open Access | Times Cited: 78
Microbiome therapeutics: exploring the present scenario and challenges
Monika Yadav, Nar Singh Chauhan
Gastroenterology report (2021) Vol. 10
Open Access | Times Cited: 72
Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering
Kristin J. Adolfsen, Isolde Callihan, Catherine Monahan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 70
Bacteria and bacterial derivatives as delivery carriers for immunotherapy
Sae‐Ryung Kang, Dinh-Huy Nguyen, Su Woong Yoo, et al.
Advanced Drug Delivery Reviews (2021) Vol. 181, pp. 114085-114085
Open Access | Times Cited: 62
Noninvasive assessment of gut function using transcriptional recording sentinel cells
Florian Schmidt, Jakob Zimmermann, Tanmay Tanna, et al.
Science (2022) Vol. 376, Iss. 6594
Open Access | Times Cited: 62
A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
Jean‐Philippe Nougayrède, Camille V. Chagneau, Jean‐Paul Motta, et al.
mSphere (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 61
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
Mark Nelson, Mark R. Charbonneau, Heidi G. Coia, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Light-Sensitive Lactococcus lactis for Microbe–Gut–Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System
Huizhuo Pan, Tao Sun, Meihui Cui, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6049-6063
Closed Access | Times Cited: 50
CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species
Linggang Zheng, Yang Tan, Yucan Hu, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 1, pp. 464-472
Closed Access | Times Cited: 48
Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy
Han Liu, Zhen Geng, Jiacan Su
Extracellular Vesicles and Circulating Nucleic Acids (2022) Vol. 3, Iss. 1, pp. 63-86
Open Access | Times Cited: 48
Recent Advances in Oral and Transdermal Protein Delivery Systems
Yinxian Yang, Ruyi Zhou, Yanfang Wang, et al.
Angewandte Chemie International Edition (2022) Vol. 62, Iss. 10
Open Access | Times Cited: 45
Genetically engineered bacterium: Principles, practices, and prospects
Yiting Liu, Jing Feng, Hangcheng Pan, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 43

Scroll to top